Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial.
Geert R A M D'HaensWalter ReinischStefan SchreiberFraser CummingsPeter M IrvingByong Duk YeDong-Hyeon KimSangwook YoonShomron Ben-HorinPublished in: Clinical drug investigation (2023)
ClinicalTrials.gov: NCT02883452.